malondialdehyde has been researched along with Iron Metabolism Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, M; Ma, L; Wang, L; Wang, W; Zhao, M | 1 |
Braga, AL; Deobald, AM; Hassan, W; Ibrahim, M; Nogueira, CW; Rocha, JB | 1 |
Kvezereli-Kopadze, AN; Kvezereli-Kopadze, MN; Mtvarelidze, ZG | 1 |
Deng, YL; Liu, XQ; Qing, H; Wang, R; Zheng, XL | 1 |
4 other study(ies) available for malondialdehyde and Iron Metabolism Disorders
Article | Year |
---|---|
Psychological stress induces dysregulation of iron metabolism in rat brain.
Topics: Animals; Brain; Disease Models, Animal; Ferritins; Iron; Iron Metabolism Disorders; Iron Regulatory Protein 1; Male; Malondialdehyde; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Stress, Psychological; Superoxide Dismutase | 2008 |
pH-dependent Fe (II) pathophysiology and protective effect of an organoselenium compound.
Topics: Animals; Antioxidants; Brain; Cytoprotection; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ferrous Compounds; Hydrogen-Ion Concentration; Imines; Iron Metabolism Disorders; Kidney; Liver; Male; Malondialdehyde; Models, Biological; Organoselenium Compounds; Phospholipids; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2009 |
[Damage of iron metabolism and oxidoreduction process in children with beta-thalassemia].
Topics: Adolescent; beta-Thalassemia; Catalase; Child; Child, Preschool; Erythrocyte Membrane; Erythropoiesis; Ferritins; Humans; Infant; Iron; Iron Metabolism Disorders; Malondialdehyde; Oxidation-Reduction; Risk Factors; Severity of Illness Index | 2006 |
Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
Topics: Apoptosis; Catechols; Cell Line, Tumor; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Hydroxyl Radical; Iron; Iron Metabolism Disorders; Isoquinolines; Malondialdehyde; Models, Biological; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease; Salsoline Alkaloids; Up-Regulation | 2008 |